Skip to main content
Premium Trial:

Request an Annual Quote

Senate Committee Passes Bill Giving FDA $50M Bump for FY 2012

NEW YORK (GenomeWeb News) – A Senate committee last week passed a bill that would give the US Food and Drug Administration a $50 million increase for fiscal-year 2012 from its FY 2011 funding levels.

The Senate Committee on Appropriations passed HR 2112, sponsored by Rep. Jack Kingston (R-Ga.), which would give FDA $2.497 billion for FY 2012, up from $2.447 billion for FY 2011, not including funds collected through user fees. According to the committee, FDA would be the only non-security agency to receive increased funding in the bill, which reduces total non-security spending by $192 million from FY 2011 levels.

The bill would provide a total of $19.780 billion in FY 2012 to FDA, the Department of Agriculture and rural development — $138 million below levels from the FY 2011 continuing resolution.

"This funding level takes into consideration the federal government's responsibilities to protect public health and safety, especially in the areas of food, drugs, medical devices, and biologics," the committee said in a summary of the bill. It added that an increase is being provided to FDA to begin implementing the recently passed Food Safety Modernization Act.

In May, the House Appropriations Committee passed a similar bill that would cut the FDA budget by $285 million.

The bill still needs passage from the full Senate. If that occurs it would need to be reconciled with the House bill.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.